Bruker (BRKR) PT Lowered to $69 at Barclays
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $62.70 +9.40%
Rating Summary:
15 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
15 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Barclays analyst Luke Sergott lowered the price target on Bruker (NASDAQ: BRKR) to $69.00 (from $75.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Assumes Bruker (BRKR) at Peerperform
- Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Ena
- Citi Downgrades Ecopetrol SA (EC) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
